Back to catalog
Tirzepatide30 mg
Metabolic Research
Tirzepatide 30 mg
Synthetic peptide — dual GIP / GLP-1 receptor agonist
$115
Quantity supplied: 30 mg per vial
For research use only • Not for human or veterinary consumption
Research overview
Synthetic dual GIP and GLP-1 receptor agonist peptide widely referenced in incretin-pathway literature.
- Incretin receptor pharmacology
- Glucose-dependent insulin secretion models
- Metabolic signalling research
Descriptions reference published scientific literature and are provided for research context only. No medical, therapeutic, or performance claims are made.
Certificate of analysis
Documentation coming soon. Contact us for available batch documentation for this compound.